Cetera Trust Company’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.53K Hold
70
﹤0.01% 328
2026
Q1
$6.03K Hold
70
﹤0.01% 329
2025
Q4
$6.11K Hold
70
﹤0.01% 330
2025
Q3
$4.01K Hold
70
﹤0.01% 346
2025
Q2
$4.13K Hold
70
﹤0.01% 351
2025
Q1
$5.12K Hold
70
﹤0.01% 344
2024
Q4
$5.79K Hold
70
﹤0.01% 342
2024
Q3
$5.01K Hold
70
﹤0.01% 368
2024
Q2
$4.79K Hold
70
﹤0.01% 369
2024
Q1
$3.75K Hold
70
﹤0.01% 396
2023
Q4
$3.73K Buy
+70
New +$3.41K ﹤0.01% 394

Other funds holding GMED

Cetera Trust Company's GMED Position: Q2 2026 in Review

Cetera Trust Company held its Globus Medical (GMED) position steady in Q2 2026 at 70 shares worth $5.53K. The position accounts for ﹤0.01% of the portfolio, ranked #328.

Cetera Trust Company first reported a position in GMED in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.11K in Q4 2025. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Cetera Trust Company held 70 shares of Globus Medical worth $5.53K as of Q2 2026.
  • Cetera Trust Company left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up ﹤0.01% of Cetera Trust Company's portfolio in Q2 2026, its #328 holding.
  • Cetera Trust Company first reported a position in Globus Medical in Q4 2023 and has held it in 11 quarters since.
  • Cetera Trust Company's Globus Medical position peaked at $6.11K in Q4 2025.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.